Top 8 Stocks To Buy Today, Potential Multibagger Stocks, Multibagger Stocks For 2025, Best Penny Stocks To Buy Today
Table of Contents
Infosys
Infosys’ Q1 net profit and revenue beats Forecaster estimates by 2% and 1.5%, respectively
Infosys Ltd. Jun-2025 Quarterly Revenue is Rs 36,157 Cr which is growth of 6.3% YoY.
Infosys Ltd. Jun-2025 Quarterly Net Profit is Rs 6,114 Cr which is growth of 6.0% YoY.
Infosys Revenue forecast
Infosys EPS Forecast
Infosys Consensus Recommendation
Also Read : Top 10 Stocks FIIs Are Buying Consistently
BEML
BEML bags a Rs 293.8 crore order from MoD to supply 150 units of heavy mobility vehicles
BEML Revenue Forecast
BEML EPS Forecast
BEML Consensus Recommendation
Dr. Reddy’s Laboratories
Dr Reddy’s Laboratories’ Q1FY26 revenue grows 12.4% YoY, beats Forecaster estimates by 2.3%
Dr. Reddy’s Laboratories Ltd. Jun-2025 Quarterly Revenue is Rs 8,208 Cr which is growth of 35.5% YoY.
Dr. Reddy’s Laboratories Ltd. Jun-2025 Quarterly Net Profit is Rs 2,961 Cr which is growth of 108.9% YoY.
Dr. Reddy’s Laboratories Revenue Forecast
Dr. Reddy’s Laboratories EPS Forecast
Dr. Reddy’s Laboratories Consensus Recommendations
Tilaknagar Industries
Tilaknagar Industries to acquire Imperial Blue whisky brand for Rs 4,150 crore
Tilaknagar Industries Revenue Forecast
Tilaknagar Industries EPS Forecast
Tilaknagar Industries Consensus Recommendations
IEX
IEX falls as electricity regulator approves implementation of market coupling from January 2026
IEX Revenue Forecast
IEX EPS Forecast
IEX Consensus Recommendations
Lupin
Lupin gets US FDA nod for Liraglutide and Glucagon injectable vials, with a market size of $458 mn
Lupin Revenue Forecast
Lupin EPS Forecast
Lupin Consensus Recommendations
Bikaji Foods International
Bikaji Foods’ Q1 profit grows 2.3% YoY to Rs 59.9 cr, EBITDA margin declines 130 bps to Rs 14.8%
Bikaji Foods International Ltd. Jun-2025 Quarterly Revenue is Rs 631 Cr which is growth of 11.0% YoY.
Bikaji Foods International Ltd. Jun-2025 Quarterly Net Profit is Rs 63 Cr which is growth of 4.3% YoY.
Bikaji Foods International Revenue Forecast
Bikaji Foods International EPS Forecast
Bikaji Foods International Consensus Recommendations
Zydus Lifesciences
Zydus Lifesciences gets US FDA approval for Ibrutinib tablets, with a market size of $2.1 billion
Zydus Lifesciences Revenue Forecast
Zydus Lifesciences EPS Forecast
Zydus Lifesciences Consensus Recommendations
Disclamer
The contents of this article are only for educational purposes and should not be considered as an investment advice in any way.
Although extreme care has been taken in preparing this article so that only genuine information is shared, readers are advised to their own research and verify all data presented in this article.
All the information covered in this article is available in public domain.
Investment in securities market risks, including the risk of loss of principal. Investors should consult with their financial advisors before making any investment decisions.
We, ‘Wealth Creatorz” shall not be liable for any direct or indirect losses arising from the use of the information provided herein.